FDA Inspection 1278383 - Avista Pharma Solutions, Inc. dba Cambrex - July 25, 2025

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Avista Pharma Solutions, Inc. dba Cambrex

Record Details

This FDA Inspection record concerns Avista Pharma Solutions, Inc. dba Cambrex, with an inspection on July 25, 2025, issued by the New England District Office, covering human drugs.

Company: Avista Pharma Solutions, Inc. dba Cambrex
Inspection Date: July 25, 2025
Product Type: Human Drugs
Office: New England District Office

Open in Dashboard

ID · 07d264c9-9218-4fc2-92ce-25f1f2348432

Violation Codes5

21 CFR 211.19221 CFR 211.22(d)21 CFR 211.56(a)21 CFR 211.5821 CFR 211.68(b)

Full citation text and observation details available on the Dashboard.